Earnings Feed
Start Free
BED BATH & BEYOND, INC.·4

Mar 12, 8:32 PM ET

TABACCO JOSEPH J JR 4

4 · BED BATH & BEYOND, INC. · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Bed Bath & Beyond (BBBY) Director Joseph Tabacco Buys 20,000 Shares

What Happened
Director Joseph J. Tabacco Jr. reported an open-market purchase of 20,000 shares of Bed Bath & Beyond (BBBY) on March 10, 2026 at a weighted average price of $5.11 per share, for a total cost of $102,200. The filing also records prior derivative awards dated October 7, 2025 (warrants), reported as acquisitions at $0.00.

Key Details

  • Transaction type/date: Open-market purchase (P) on 2026-03-10 — 20,000 shares @ $5.11 avg = $102,200. Prices per share in the underlying trades ranged from $5.07 to $5.13 (F1).
  • Earlier reported acquisitions (A) on 2025-10-07: 1,150 and 14,720 derivative instruments reported at $0.00 (these represent warrants) (F3).
  • Warrants detail (F3): Each warrant entitles the holder to buy one share at $15.50; these were distributed pro rata on Oct 7, 2025 and that distribution was exempt from immediate Section 16 reporting.
  • Ownership after transaction: not specified in this Form 4 filing.
  • Relationship note: Mr. Tabacco is trustee and beneficiary of the Joseph Tabacco and Peggy Schmidt Revocable Trust (F2).
  • Filing timeliness: Reported on 2026-03-12 for a 2026-03-10 transaction — filed within the usual two-business-day window.

Context

  • The primary action was a straightforward open-market purchase (a net buy), which many retail investors view as a more informative signal than routine sales because it reflects capital put to work.
  • The October 2025 entries are derivative warrants (not exercises); they give the right to buy shares at $15.50 and are distinct from the March 2026 cash purchase.
  • No indication of tax withholding, 10b5-1 plan, cashless exercise, or gifting in this filing.

Insider Transaction Report

Form 4
Period: 2026-03-10
BED BATH & BEYOND, INC.BBBY
TABACCO JOSEPH J JR
Director
Transactions
  • Purchase

    Common Stock

    [F1][F2]
    2026-03-10$5.11/sh+20,000$102,200→ 167,209 total(indirect: By Trust)
  • Award

    Common Stock Warrant

    [F3]
    2025-10-07+1,150→ 1,150 total
    Exercise: $15.50From: 2025-12-03Exp: 2026-10-07→ Common Stock (1,150 underlying)
  • Award

    Common Stock Warrant

    [F3][F2]
    2025-10-07+14,720→ 14,720 total(indirect: By Trust)
    Exercise: $15.50From: 2025-12-03Exp: 2026-10-07→ Common Stock (14,720 underlying)
Holdings

  • Common Stock

    11,506
Footnotes (3)
  • [F1]$5.11 is the weighted average purchase price for the 20,000 shares purchased on March 10, 2026. The shares were purchased in multiple transactions at prices ranging from $5.07 to $5.13 per share, inclusive. The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Mr. Tabacco is trustee and beneficiary of the Joseph Tabacco and Peggy Schmidt Revocable Trust.
  • [F3]Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
Signature
/s/ Christina Wheeler, Attorney-in-Fact|2026-03-12

Documents

1 file
  • 4
    form4-03132026_120339.xmlPrimary